Home ›
Trademark Categories ›
Pharmaceuticals ›
2006 ›
NE ›
NEXTUBIN
Trademark search for:
NEXTUBIN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-10-13 — Application filed
2014-10-16 — Application filed
2014-10-17 — Application filed
2015-01-31 — Assigned to examiner
2015-02-07 — Final disposition recorded
2015-02-07 — Final disposition recorded
2015-02-07 — Final disposition recorded
2015-08-17 — Office action issued
2015-08-17 — Petition to revive-granted
2015-08-17 — Correspondence received in law office
2015-08-17 — Teas petition to revive received
2015-08-18 — Teas/email correspondence entered
2015-08-18 — Notice of revival - e-mailed
2015-08-19 — Approved for pub - principal register
2015-09-13 — Assigned to lie
2015-09-15 — Law office publication review completed
2015-09-30 — Notification of notice of publication e-mailed
2015-10-20 — Published for opposition
2015-10-20 — Official gazette publication confirmation e-mailed
2015-12-15 — Noa e-mailed - sou required from applicant
2016-06-15 — Sou teas extension received
2016-06-15 — Sou extension 1 filed
2016-06-15 — Sou extension 1 granted
2016-06-17 — Notice of approval of extension request e-mailed
2016-12-15 — Sou teas extension received
2016-12-15 — Sou extension 2 filed
2016-12-15 — Sou extension 2 granted
2016-12-17 — Notice of approval of extension request e-mailed
2017-06-15 — Sou teas extension received
2017-06-15 — Sou extension 3 filed
2017-06-15 — Sou extension 3 granted
2017-06-17 — Notice of approval of extension request e-mailed
2018-01-15 — Application abandoned
2018-01-15 — Final status recorded
2018-01-16 — Application abandoned
Owner Information
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Correspondent
MARILYN F. KELLY BRISTOL-MYERS SQUIBB COMPANY
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
